FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.
Masy Systems
Masy Systems helps life science companies analyze and improve the quality of their research laboratories and production environments, playing a focused role in the development and delivery of leading drugs and devices used to improve patients’ lives.
To control life science product quality, you have to control the process — which includes accurate and precise measurement of all the variables that affect the successful development and production of life-improving technologies. Masy's integrated suite of calibration capabilities, validation services, biorepository facility, and equipment inventory can help ensure measurement accuracy in your key processes.
More companies from this Category
PharmTech News Articles
The company announced an investment in a new facility in Dundalk, County Louth, Ireland.
Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.
Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.